Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 22;14(15):5200.
doi: 10.3390/jcm14155200.

Infections with Staphylococcus spp. in Children Undergoing Anticancer Therapy or Haematopoietic Cell Transplantation: A Nationwide Multicentre Study

Affiliations

Infections with Staphylococcus spp. in Children Undergoing Anticancer Therapy or Haematopoietic Cell Transplantation: A Nationwide Multicentre Study

Anna Jabłońska et al. J Clin Med. .

Abstract

Background: Staphylococcus spp. represent the most prevalent Gram-positive organisms in children with malignancies or undergoing haematopoietic cell transplantation (HCT), contributing to significant morbidity and mortality. This study aimed to assess the epidemiology, risk factors, treatment strategies, and outcomes of staphylococcal infections (SIs) in paediatric haemato-oncology (PHO) and HCT patients in Poland over a 12-year period. Methods: A retrospective, multicentre study was conducted across 17 paediatric oncology centres in Poland. The clinical and microbiological data of patients under the age of 18, diagnosed with malignancies or post-HCT, were analysed for confirmed SI between 2012 and 2023. The variables assessed included demographics, underlying conditions, infection type and source, antimicrobial susceptibility, treatment, and 30-day infection-free survival. Results: Among 1725 patients with SI, 1433 were PHO and 292 were HCT patients. The cumulative incidence of SI was 12.7% in PHO and 14.3% in HCT patients (p = 0.008). The 30-day survival rate was significantly higher in PHO compared to HCT patients (98.4% vs. 93.2%, p < 0.001). Most deaths were caused by S. epidermidis, S. haemolyticus, and S. hominis, predominantly involving methicillin-resistant coagulase-negative Staphylococci (MRCNS). Multivariate Cox regression identified undergoing HCT (HR = 3.0, 95% CI: 1.6-5.6, p < 0.001) and treatment of infection > 10 days (HR = 2.0, 95% CI: 1.1-3.6, p = 0.019) as independent risk factors for mortality. Conclusions: Staphylococcal infections pose a significant challenge in paediatric oncology and transplant populations. Optimising prevention, diagnostics, and antimicrobial therapy is crucial for improving outcomes in these high-risk groups.

Keywords: Staphylococcus; bacteraemia; haematopoietic cell transplantation; infection; leukaemia; oncology; paediatric malignancy.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to disclose.

Figures

Figure 1
Figure 1
Cumulative incidence of infections with Staphylococcus spp. in HCT and PHO patients, with respect to the most common primary diseases and two-year time intervals. (a) Total, PHO vs. HCT; (b) ALL, PHO vs. HCT; (c) AML, PHO vs. HCT; (d) MDS, PHO vs. HCT; (e) NBL, PHO vs. HCT; (f) NHL, PHO vs. HCT; (g) PHO, 2012–2013 vs. 2014–2015 vs. 2016–2017; (h) PHO, 2018–2019 vs. 2020–2021 vs. 2022–2023; (i) HCT, 2012–2013 vs. 2014–2015 vs. 2016–2017; (j) HCT 2018–2019 vs. 2020–2021 vs. 2022–2023.
Figure 2
Figure 2
Survival from staphylococcal infection in PHO and HCT settings, with respect to the most common primary diseases and two-year time intervals. (a) Total, PHO vs. HCT; (b) ALL, PHO vs. HCT; (c) AML, PHO vs. HCT; (d) MDS, PHO vs. HCT; (e) PHO, 2012–2013 vs. 2014–2015 vs. 2016–2017; (f) PHO, 2018–2019 vs. 2020–2021 vs. 2022–2023; (g) HCT, 2012–2013 vs. 2014–2015 vs. 2016–2017; (h) HCT 2018–2019 vs. 2020–2021 vs. 2022–2023.

Similar articles

References

    1. Styczynski J., Czyzewski K., Wysocki M., Gryniewicz-Kwiatkowska O., Kolodziejczyk-Gietka A., Salamonowicz M., Hutnik L., Zajac-Spychala O., Zaucha-Prazmo A., Chelmecka-Wiktorczyk L., et al. Increased Risk of Infections and Infection-Related Mortality in Children Undergoing Haematopoietic Stem Cell Transplantation Compared to Conventional Anticancer Therapy: A Multicentre Nationwide Study. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2016;22 doi: 10.1016/j.cmi.2015.10.017. - DOI - PubMed
    1. Al-Mulla N.A., Taj-Aldeen S.J., El Shafie S., Janahi M., Al-Nasser A.A., Chandra P. Bacterial Bloodstream Infections and Antimicrobial Susceptibility Pattern in Pediatric Hematology/Oncology Patients after Anticancer Chemotherapy. Infect. Drug Resist. 2014;7:289–299. doi: 10.2147/IDR.S70486. - DOI - PMC - PubMed
    1. Zając-Spychała O., Wachowiak J., Pieczonka A., Siewiera K., Frączkiewicz J., Kałwak K., Gorczyńska E., Chybicka A., Czyżewski K., Jachna-Sawicka K., et al. Bacterial Infections in Pediatric Hematopoietic Stem Cell Transplantation Recipients: Incidence, Epidemiology, and Spectrum of Pathogens: Report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation. Transpl. Infect. Dis. Off. J. Transplant. Soc. 2016;18:690–698. doi: 10.1111/tid.12581. - DOI - PubMed
    1. Tong S.Y.C., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management. Clin. Microbiol. Rev. 2015;28:603–661. doi: 10.1128/CMR.00134-14. - DOI - PMC - PubMed
    1. Demiselle J., Meyer P., Lavigne T., Kaurin J., Merdji H., Schenck M., Studer A., Janssen-Langenstein R., Helms J., Hoellinger B., et al. Staphylococcus Epidermidis Bloodstream Infections Are a Cause of Septic Shock in Intensive Care Unit Patients. Int. J. Infect. Dis. 2023;135:45–48. doi: 10.1016/j.ijid.2023.07.014. - DOI - PubMed

LinkOut - more resources